首页|Sichuan University Reports Findings in Artificial Intelligence (Multiomics and artificial intelligence predict clinical outcomes of immunotherapy in non-small cell lung cancer patients)
Sichuan University Reports Findings in Artificial Intelligence (Multiomics and artificial intelligence predict clinical outcomes of immunotherapy in non-small cell lung cancer patients)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News – New research on Artificial Intelligenc e is the subject of a report. According to newsreporting from Sichuan, People’s Republic of China, by NewsRx journalists, research stated, “In recentyears, va rious types of immunotherapy, particularly the use of immune checkpoint inhibito rs targetingprogrammed cell death 1 or programmed death ligand 1 (PD-L1), have revolutionized the managementand prognosis of non-small cell lung cancer. PD-L1 is frequently used as a biomarker for predicting thelikely benefit of immunoth erapy for patients.”
SichuanPeople’s Republic of ChinaAsi aArtificial IntelligenceCancerDrugs and TherapiesEmerging TechnologiesHealth and MedicineImmunotherapyLung CancerLung Diseases and ConditionsL ung NeoplasmsMachine LearningNon-Small Cell Lung
NETL
NSTL
